Pathogenesis and possibilities of an individulized MS therapy
Research report (imported) 2006 - Max Planck Institute of Psychiatry
Multiple Sclerosis (MS) is a heterogenous, chronic inflammatory, demyelinating disease of the central nervous system (CNS). Despite of many research efforts the cause of MS is unknown. Today new techniques allow the investigation of nearly the whole genome, transcriptome and proteome. The Max-Planck-Institute of Psychiatry uses these techniques to explore the pathogenesis of MS and to open the possibility for an individualized therapy.